LAG-3 is also highly expressed on tumor-infiltrating lymphocytes (TILs) in a variety of cancers8 and has been considered an emerging immune checkpoint in the tumor microenvironment with implications for cancer immunotherapy9. Here, LAG3 is linked to neoplasm.